Abstract:Background: The exposure levels of phthalates in humans have dropped dramatically. Little is known about the individual and joint effects of phthalates exposure at low levels on the risk of early miscarriage. Objective: To examine the association between exposure to phthalates individually or as a mixture and early miscarriage. Methods: A case-control study was conducted in Shanghai, China during 2019-2020. A total of 291 women seeking medical services due to miscarriage (cases) and 308 women planning to terminate an unintended pregnancy (controls) within 12 gestational weeks were recruited. Urinary concentrations of eight phthalate metabolites were determined by ultra-performance liquid chromatography. We included 534 women in the main analysis who had available data on both phthalates exposure and complete information on potential confounders. We used logistic regression and Bayesian kernel machine regression (BKMR) to examine the associations of concentrations of phthalates with miscarriage. Results: Among the phthalate metabolites, mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) had the highest concentration (8.10 ng/mL), followed by mono(2-ethyl-5-oxohexyl) phthalate (MEOHP, 2.68 ng/mL) and monobutyl phthalate (MBP, 2.24 ng/mL). Higher concentrations of MBP, mono(2-ethylhexyl) phthalate (MEHP), MEHHP, MEOHP and the molar sum of di(2-ethylhexyl) phthalate (DEHP) metabolites (∑DEHPm) were associated with an increased risk of miscarriage exhibiting a dose-response relationship. The most evident association of miscarriage was found with ∑DEHPm, with adjusted odds ratio (95% confidence interval) of 1.94 (1.14, 3.31) for the second quartile, 2.83 (1.67, 4.79) for the third quartile and 4.28 (2.49, 7.37) for the fourth quartile compared to the first quartile. Consistently, the phthalate mixture was positively associated with the risk of miscarriage and DEHP was the predominant contributor to the joint effect in BKMR model. Impact: Phthalates are a family of synthetic chemicals mainly used as plasticizers, solvents and additives in a large variety of industrial and consumer products, including food packing materials, toys, gloves, medical devices and personal care products. Although exposure levels of phthalates of pregnant women have declined sharply over the past few decades, phthalates exposure was still associated with an increased risk of early miscarriage. Our findings suggest that future researchers and policy makers might need to take low-dose effects of phthalates into account regarding the reproductive toxicity of phthalates exposure in humans. Significance: Our findings contribute to the awareness of the reproductive toxic potential of phthalates at low levels in humans and support the ongoing efforts to further reduce exposure to phthalates.

Associations between exposure to phthalates and liver function among women undergoing assisted reproductive technology

Phthalate Exposures, Blood Coagulation Function, and Assisted Reproductive Technology Outcomes: Results from the TREE Cohort Study

The Associations of Urinary Phthalate Metabolites with the Intermediate and Pregnancy Outcomes of Women Receiving IVF/ICSI Treatments: A Prospective Single-Center Study.

Associations between urinary phthalate metabolite concentrations and markers of liver injury in the US adult population

Associations between medication use and phthalate metabolites in urine and follicular fluid among women undergoing in vitro fertilization

Follicular Fluid and Urinary Concentrations of Phthalate Metabolites among Infertile Women and Associations with in Vitro Fertilization Parameters

Associations between urinary phthalate concentrations and antral follicle count among women undergoing in vitro fertilization

Associations Between Phthalate Metabolites and Cytokines in the Follicular Fluid of Women Undergoing in Vitro Fertilization.

The association of serum phthalate metabolites with biomarkers of ovarian reserve in women of childbearing age

Associations Between Phthalate Metabolite Concentrations in Follicular Fluid and Reproductive Outcomes among Women Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment.

Association of phthalate exposure with low birth weight in couples conceiving naturally or via assisted reproductive technology in a prospective birth cohort

Associations Between Phthalate Exposure and Thyroid Function in Pregnant Women During the First Trimester.

Phthalate metabolites and biomarkers of oxidative stress in the follicular fluid of women undergoing in vitro fertilization

Predictors of Phthalate Metabolites in Urine and Follicular Fluid and Correlations Between Urine and Follicular Fluid Phthalate Metabolite Concentrations among Women Undergoing in Vitro Fertilization.

Associations Betweenphthalatemetaboliteconcentrationsinfollicularfluidand Reproductive OutcomesamongWomenUndergoing in Vitro Fertilization/ Intracytoplasmic SpermInjectionTreatment

Phthalate Exposure in Association with Serum Hormone Levels, Sperm DNA Damage and Spermatozoa Apoptosis: A Cross-Sectional Study in China

Urinary phthalate metabolites in pregnant women: occurrences, related factors, and association with maternal hormones

Follicular Fluid Concentrations of Phthalate Metabolites Are Associated with Altered Intrafollicular Reproductive Hormones in Women Undergoing in Vitro Fertilization

Urinary Levels of Phthalate Metabolites in Women Associated with Risk of Premature Ovarian Failure and Reproductive Hormones.

Individual and joint effects of phthalates exposure on the risk of early miscarriage

Combined Effects and Potential Mechanisms of Phthalate Metabolites on Serum Sex Hormones among Reproductive-Aged Women: an Integrated Epidemiology and Computational Toxicology Study